Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E Rudd

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Frontiers in Immunology|December 25, 2014
Diverse mechanisms regulate the surface expression of immunotherapeutic target ctla-4Helga Schneider, Christopher E Rudd
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 27, 2003
Hematopoietic adaptors in T-cell signaling: potential applications to transplantationChristopher E Rudd, Hongyan Wang
Advances in Experimental Medicine and Biology|October 3, 2019
Small Molecule Inhibition of Glycogen Synthase Kinase-3 in Cancer ImmunotherapyAlison Taylor, Christopher E Rudd
Frontiers in Immunology|January 10, 2018
Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8<sup>+</sup> Cytotoxic T-Cells: Implications for anti-PD-1 ImmunotherapyAlison Taylor, Christopher E Rudd
Biochemical and Biophysical Research Communications|February 26, 2008
CD28 and Grb-2, relative to Gads or Grap, preferentially co-operate with Vav1 in the activation of NFAT/AP-1 transcriptionHelga Schneider, Christopher E Rudd
Journal of Immunological Sciences|May 22, 2019
Commentary: Small Molecule Inhibition of PD-1 Transcription is an Effective Alternative to Antibody Blockade in Cancer TherapyAlison Taylor, Christopher E Rudd
Cellular & Molecular Immunology|April 2, 2025
Comment on: Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activationBastien Moës, Christopher E Rudd
Biomolecules|August 28, 2025
CD4/CD8-p56<sup>lck</sup> Induced T-Cell Receptor Signaling and Its Implications for ImmunotherapyAndres Oroya, Christopher E Rudd
Trends in Cell Biology|September 2, 2008
SKAP-55, SKAP-55-related and ADAP adaptors modulate integrin-mediated immune-cell adhesionHongyan Wang, Christopher E Rudd
Journal of Cellular Immunology|June 13, 2022
Glycogen Synthase Kinase-3 (GSK-3) Regulation of Inhibitory Coreceptor Expression in T-cell ImmunityMark E Issa, Christopher E Rudd
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Frontiers in Immunology|December 25, 2014
Diverse mechanisms regulate the surface expression of immunotherapeutic target ctla-4Helga Schneider, Christopher E Rudd
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 27, 2003
Hematopoietic adaptors in T-cell signaling: potential applications to transplantationChristopher E Rudd, Hongyan Wang
Advances in Experimental Medicine and Biology|October 3, 2019
Small Molecule Inhibition of Glycogen Synthase Kinase-3 in Cancer ImmunotherapyAlison Taylor, Christopher E Rudd
Frontiers in Immunology|January 10, 2018
Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8<sup>+</sup> Cytotoxic T-Cells: Implications for anti-PD-1 ImmunotherapyAlison Taylor, Christopher E Rudd
Biochemical and Biophysical Research Communications|February 26, 2008
CD28 and Grb-2, relative to Gads or Grap, preferentially co-operate with Vav1 in the activation of NFAT/AP-1 transcriptionHelga Schneider, Christopher E Rudd
Journal of Immunological Sciences|May 22, 2019
Commentary: Small Molecule Inhibition of PD-1 Transcription is an Effective Alternative to Antibody Blockade in Cancer TherapyAlison Taylor, Christopher E Rudd
Cellular & Molecular Immunology|April 2, 2025
Comment on: Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activationBastien Moës, Christopher E Rudd
Biomolecules|August 28, 2025
CD4/CD8-p56<sup>lck</sup> Induced T-Cell Receptor Signaling and Its Implications for ImmunotherapyAndres Oroya, Christopher E Rudd
Trends in Cell Biology|September 2, 2008
SKAP-55, SKAP-55-related and ADAP adaptors modulate integrin-mediated immune-cell adhesionHongyan Wang, Christopher E Rudd
Journal of Cellular Immunology|June 13, 2022
Glycogen Synthase Kinase-3 (GSK-3) Regulation of Inhibitory Coreceptor Expression in T-cell ImmunityMark E Issa, Christopher E Rudd
Pageof 12